Thng, Zheng Xian; Putera, Ikhwanuliman; Testi, Ilaria; Chan, Kevin; Westcott, Mark; Chee, Soon-Phaik; Dick, Andrew D; ... TITAN consensus guidelines group; + view all Thng, Zheng Xian; Putera, Ikhwanuliman; Testi, Ilaria; Chan, Kevin; Westcott, Mark; Chee, Soon-Phaik; Dick, Andrew D; Kempen, John H; Bodaghi, Bahram; Thorne, Jennifer E; Barisani-Asenbauer, Talin; De Smet, Marc D; Smith, Justine R; McCluskey, Peter; La Distia Nora, Rina; Jabs, Douglas A; De Boer, Joke H; Sen, H Nida; Goldstein, Debra A; Khairallah, Moncef; Davis, Janet L; Rosenbaum, James T; Jones, Nicholas P; Nguyen, Quan Dong; Pavesio, Carlos; Agrawal, Rupesh; Gupta, Vishali; TITAN consensus guidelines group; - view fewer (2024) The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2—global current practice patterns for the management of Cytomegalovirus anterior uveitis. Eye , 38 pp. 68-75. 10.1038/s41433-023-02631-8.

Preview	Text (Article) Dick_TITAN CMV AU EYE revision100223.pdf Download (252kB) | Preview
Preview	Text (Supplementary File 1) Supp file 1 CMV LIterature Review.pdf - Accepted Version Download (215kB) | Preview
Preview	Text (Supplementary File 2) Supp file 2 CMV Delphi 1 Survey new.pdf - Accepted Version Download (220kB) | Preview
Preview	Text (Supplementary File 3) Supp file 3 CMV Delphi 2 Survey new.pdf - Accepted Version Download (383kB) | Preview
Preview	Text (Supplementary File 4) Supp file 4 new.pdf - Accepted Version Download (96kB) | Preview
Preview	Text (Table 1) Dick_Table 1 TITAN CMV.pdf Download (29kB) | Preview
Preview	Text (Table 2) Dick_Table 2 TITAN CMV.pdf Download (91kB) | Preview
Preview	Text (Table 3) Dick_Table 3 TITAN CMV.pdf Download (61kB) | Preview
Preview	Text (Table 4) Dick_Table 4 TITAN CMV.pdf Download (78kB) | Preview

Abstract

AIMS: To present current practice patterns in the diagnosis and management of Cytomegalovirus anterior uveitis (CMV AU) by uveitis experts worldwide. METHODS: A two-round modified Delphi survey with masking of the study team was performed. Based on experience and expertise, 100 international uveitis specialists from 21 countries were invited to participate in the survey. Variation in the diagnostic approaches and preferred management of CMV AU was captured using an online survey platform. RESULTS: Seventy-five experts completed both surveys. Fifty-five of the 75 experts (73.3%) would always perform diagnostic aqueous tap in suspected CMV AU cases. Consensus was achieved for starting topical antiviral treatment (85% of experts). About half of the experts (48%) would only commence systemic antiviral treatment for severe, prolonged, or atypical presentation. The preferred specific route was ganciclovir gel 0.15% for topical treatment (selected by 70% of experts) and oral valganciclovir for systemic treatment (78% of experts). The majority of experts (77%) would commence treatment with topical corticosteroid four times daily for one to two weeks along with antiviral coverage, with subsequent adjustment depending on the clinical response. Prednisolone acetate 1% was the drug of choice (opted by 70% of experts). Long-term maintenance treatment (up to 12 months) can be considered for chronic course of inflammation (88% of experts) and those with at least 2 episodes of CMV AU within a year (75-88% of experts). CONCLUSIONS: Preferred management practices for CMV AU vary widely. Further research is necessary to refine diagnosis and management and provide higher-level evidence.

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as CSVXMLJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item